Fresh off a pivot from commercial pharma business to preclinical biotech, Aadi Bioscience has rebranded to better match its strategic reboot. More: Aadi Bioscience takes flight with new moniker: Whitehawk Therapeutics Source: fierce
read moreWith the fate of the BIOSECURE Act currently in limbo, WuXi AppTec is looking on the brighter side for 2025. Still, geopolitical uncertainties under the second Trump administration loom large over the Chinese contract research and manufacturing giant’s future. More:
read more
The agency has launched a whole genome sequencing service to monitor the virus More: UKHSA announces new effort to tackle hepatitis C Source: News
read moreAll of the drugmakers that market the 15 drugs selected for the second cycle of Inflation Reduction Act (IRA)-mandated price cuts agreed to participate in the upcoming negotiation process. More: IRA round 2 begins as drugmakers sign on to price
read moreIn a proposed amicus brief, Eli Lilly, Johnson & Johnson, Pfizer and Sanofi have backed a Teva lawsuit against the Centers for Medicare & Medicaid Services (CMS) for how it is implementing the Inflation Reduction Act’s drug price negotiation program. More:
read moreOne patient with Duchenne muscular dystrophy has passed away following treatment with Sarepta Therapeutics’ gene therapy Elevidys, the biotech said Tuesday. More: Sarepta reports 1 death after patient received DMD gene therapy Elevidys Source: fierce
read more© 1994 - 2025 B.M. Pharmaceuticals